Propylamine → [2-(4-Phenylpiperazin-1-yl)-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]propylamine
Reaktionsgleichung
Cl[C:2]1[C:3]2[S:22][CH2:21][CH2:20][C:4]=2[N:5]=[C:6]([N:8]2[CH2:13][CH2:12][N:11]([C:14]3[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=3)[CH2:10][CH2:9]2)[N:7]=1.[CH2:23]([NH2:26])[CH2:24][CH3:25]>O>[C:14]1([N:11]2[CH2:12][CH2:13][N:8]([C:6]3[N:7]=[C:2]([CH2:25][CH2:24][CH2:23][NH2:26])[C:3]4[S:22][CH2:21][CH2:20][C:4]=4[N:5]=3)[CH2:9][CH2:10]2)[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=1Komponenten
4
Versuchsvorschrift
0.83 g (2.5 mmol) of 4-chloro-2-(4-phenylpiperazin-1-yl)-6,7-dihydrothieno[3,2-d]pyrimidine (V) is combined with 8.3 mL of n-propylamine, reacted for 0.2 hours at 130° C. in the microwave. Then the reaction mixture is added to water and extracted with dichloromethane. The organic phase is concentrated by evaporation, the residue is crystallized. The aqueous phase is extracted with ethyl acetate, the organic phase evaporated to dryness. The solids are combined and stirred with methanol. 0.68 g of the product (76%) is obtained as a powder.
Aufarbeitung
- customreacted for 0.2 hours at 130° C. in the microwave
- extractionextracted with dichloromethane
- concentrationThe organic phase is concentrated by evaporation
- customthe residue is crystallized
- extractionThe aqueous phase is extracted with ethyl acetate
- customthe organic phase evaporated to dryness
Quellen und Nachweise
- ORD-Eintrag
- ord-81fb7300023348a38472587f3d8f6f50
- Quelldatensatz
- uspto-grants-2013_01
- Patentnummer
- US08354531B2
Notizen zur Reaktion
Wird geladen…